Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination of chlorthalidone, a thiazide-like diuretic primarily used to treat hypertension and edema, with potassium chloride, an electrolyte supplement used to prevent or treat low blood potassium (hypokalemia). Chlorthalidone works by inhibiting the sodium-chloride symporter in the distal convoluted tubule of the kidneys, reducing sodium and chloride reabsorption and increasing water excretion. This action decreases fluid volume and peripheral vascular resistance, helping normalize blood pressure. However, this mechanism also leads to increased potassium excretion, which can cause hypokalemia. Potassium chloride supplements are included to prevent or treat this hypokalemia, as potassium is essential for several bodily functions, particularly heart function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorthalidone + potassium chloride.